[Articles] Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

We have developed an externally validated model to predict survival without tracheostomy and non-invasive ventilation for more than 23 h per day in European patients with ALS. This model could be applied to individualised patient management, counselling, and future trial design, but to maximise the benefit and prevent harm it is intended to be used by medical doctors only.
Source: Lancet Neurology - Category: Neurology Authors: Tags: Articles Source Type: research
More News: ALS | Brain | Neurology | Tracheostomy